
    
      This study will be reopened and will continue the inclusion due to underpowered results.

      A new application to the Ethical committee was submitted. Approval to reopen this RCT-study
      was received at 27th of September 2018 (dnr 218/445-32).

      Additional inclusion of 40 additional patients will start at 1th of November 2018. Data from
      baseline to 12 months follow-up (as described in protocol) will be collected. Inclusion
      continued and the last inklusion was completed in February 2020. Data Collection for all
      follow ups is anticipated to be completed at latest during March the year of 2021.
    
  